Investing.com -- Illumina Inc. (NASDAQ:ILMN) reported fourth-quarter earnings that beat analyst expectations, but shares plunged 8.7% in after-hours trading Thursday as the company’s flat annual ...

SAN DIEGO (AP) — SAN DIEGO (AP) — Illumina Inc. (ILMN) on Thursday reported fourth-quarter net income of $334 million. On a per-share basis, the San Diego-based company said it had profit of $2.16.

Illumina, Inc. (NASDAQ: ILMN) today announced a sequencing agreement with the San Diego Zoo Wildlife Alliance (SDZWA)'s ...

Illumina, Inc. (NASDAQ: ILMN) today announced that it has completed its acquisition of SomaLogic, a leader in data-driven ...

We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. Illumina Inc. is another one of the best cancer stocks on our list. TheFly reported on January 7 that TD Cowen raised its price ...

In the prior quarter, Illumina delivered earnings of $1.34 per share, beating the $1.17 consensus by 14.5%, on revenue of $1.08 billion that topped estimates by nearly 1%. That performance was driven ...

Illumina currently carries a Zacks Rank #3 (Hold). Some better-ranked stocks in the broader medical space are IDEXX Laboratories IDXX, Boston Scientific BSX and STERIS STE. Each of these carries a ...

Illumina, Inc.'s acquisition of GRAIL, Inc. was disastrous and created all kinds of problems, but the company is refocusing on its profitable core gene sequencing business. ILMN's revenue growth has ...

Illumina, Inc. (NASDAQ:ILMN) shares are trading higher after announcing preliminary financial results for the fourth quarter (Q4) and fiscal year 2023. For Q4, the company reported preliminary ...

Shares of Illumina Inc. ILMN shed 3.26% to $144.81 Friday, on what proved to be an all-around poor trading session for the ...

Industries across the board today are facing the challenge of integrating cutting-edge technologies with established infrastructures. Companies are bringing together different data systems using data ...

On Monday, Illumina, Inc. (NASDAQ:ILMN) agreed to acquire Standard BioTools’ (NASDAQ:LAB) subsidiary, SomaLogic. Following the announcement of the acquisition, Standard BioTools’ stock experienced a ...